Ilex Medical Ltd (TLV: ILX)
Israel
· Delayed Price · Currency is ILS · Price in ILA7,483.00
-440.00 (-5.55%)
Dec 19, 2024, 5:24 PM IDT
Ilex Medical Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 982.96 | 930.89 | 872.54 | 1,061 | 946.45 | 633.96 | Upgrade
|
| Revenue Growth (YoY) | 11.75% | 6.69% | -17.76% | 12.10% | 49.29% | 5.46% | Upgrade
|
| Cost of Revenue | 753.08 | 699.02 | 587.44 | 681.61 | 675.43 | 440.2 | Upgrade
|
| Gross Profit | 229.88 | 231.87 | 285.1 | 379.38 | 271.02 | 193.76 | Upgrade
|
| Selling, General & Admin | 151.53 | 149.31 | 138.92 | 126.84 | 117.95 | 112.17 | Upgrade
|
| Research & Development | 10.49 | 9.73 | 9.4 | 8.35 | 8.42 | 7.57 | Upgrade
|
| Other Operating Expenses | -1.14 | -0.02 | -2.1 | -1.95 | -1.86 | -1.74 | Upgrade
|
| Operating Expenses | 160.88 | 159.02 | 146.23 | 133.24 | 124.51 | 118 | Upgrade
|
| Operating Income | 69 | 72.85 | 138.88 | 246.14 | 146.51 | 75.76 | Upgrade
|
| Interest Expense | - | -1.8 | -1.61 | -1.97 | -2.34 | -2.62 | Upgrade
|
| Interest & Investment Income | 10.15 | 0.6 | 5.77 | 1.86 | 0.85 | 1.32 | Upgrade
|
| Earnings From Equity Investments | -6.48 | -4.01 | -2.69 | -0.26 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 1.03 | 1.03 | -8.56 | -1.59 | 5.12 | 5.86 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.88 | -3.88 | -14.3 | 7.4 | 3.94 | 0.66 | Upgrade
|
| EBT Excluding Unusual Items | 69.83 | 64.79 | 117.5 | 251.58 | 154.07 | 80.98 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.37 | 4.37 | -2.72 | 3.78 | 0.09 | 3.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.24 | 0.24 | 21.96 | -0.01 | -0.36 | 1.05 | Upgrade
|
| Pretax Income | 74.44 | 69.4 | 136.74 | 255.35 | 153.8 | 85.48 | Upgrade
|
| Income Tax Expense | 19.63 | 18.52 | 34.62 | 57.87 | 27.83 | 20.95 | Upgrade
|
| Earnings From Continuing Operations | 54.81 | 50.89 | 102.12 | 197.48 | 125.97 | 64.53 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -5.35 | -4.28 | Upgrade
|
| Net Income | 54.81 | 50.89 | 102.12 | 197.48 | 120.62 | 60.26 | Upgrade
|
| Net Income to Common | 54.81 | 50.89 | 102.12 | 197.48 | 120.62 | 60.26 | Upgrade
|
| Net Income Growth | -17.74% | -50.17% | -48.29% | 63.72% | 100.18% | 28.26% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 10 | Upgrade
|
| Shares Change (YoY) | -0.25% | -0.79% | -0.02% | 5.73% | 6.33% | - | Upgrade
|
| EPS (Basic) | 4.90 | 4.55 | 9.05 | 17.51 | 11.30 | 6.00 | Upgrade
|
| EPS (Diluted) | 4.90 | 4.55 | 9.05 | 17.50 | 11.24 | 6.00 | Upgrade
|
| EPS Growth | -17.47% | -49.75% | -48.29% | 55.66% | 87.41% | 28.21% | Upgrade
|
| Free Cash Flow | 82.85 | 31.66 | 43.6 | 229.73 | 138.1 | 54.98 | Upgrade
|
| Free Cash Flow Per Share | 7.40 | 2.83 | 3.87 | 20.36 | 12.94 | 5.48 | Upgrade
|
| Dividend Per Share | 1.365 | 1.365 | 1.917 | 5.319 | 5.319 | - | Upgrade
|
| Dividend Growth | -28.80% | -28.80% | -63.97% | 0% | - | - | Upgrade
|
| Gross Margin | 23.39% | 24.91% | 32.67% | 35.76% | 28.64% | 30.56% | Upgrade
|
| Operating Margin | 7.02% | 7.83% | 15.92% | 23.20% | 15.48% | 11.95% | Upgrade
|
| Profit Margin | 5.58% | 5.47% | 11.70% | 18.61% | 12.74% | 9.50% | Upgrade
|
| Free Cash Flow Margin | 8.43% | 3.40% | 5.00% | 21.65% | 14.59% | 8.67% | Upgrade
|
| EBITDA | 103.32 | 106.37 | 175.2 | 296.63 | 186.4 | 113.22 | Upgrade
|
| EBITDA Margin | 10.51% | 11.43% | 20.08% | 27.96% | 19.70% | 17.86% | Upgrade
|
| D&A For EBITDA | 34.32 | 33.52 | 36.32 | 50.49 | 39.89 | 37.47 | Upgrade
|
| EBIT | 69 | 72.85 | 138.88 | 246.14 | 146.51 | 75.76 | Upgrade
|
| EBIT Margin | 7.02% | 7.83% | 15.92% | 23.20% | 15.48% | 11.95% | Upgrade
|
| Effective Tax Rate | 26.37% | 26.68% | 25.32% | 22.66% | 18.10% | 24.51% | Upgrade
|
| Advertising Expenses | - | 3.7 | 3.4 | 1.4 | 1.89 | 3.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.